LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the UBS Global Life Sciences Conference on Monday, September 22, 2008 at 4:00 p.m. (ET) at the Grand Hyatt New York.
